Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of Components of Marketable Securities

The following is a summary of the components of our marketable debt securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):

 

    As of March 31, 2021  
    Amortized     Unrealized     Fair  
    Cost     Losses     Value  
U.S. government obligations   $ 1,021     $ (12 )   $ 1,009  
Corporate obligations     2,533       (11 )     2,522  
    $ 3,554     $ (23 )   $ 3,531  

 

    As of December 31, 2020  
    Amortized     Unrealized     Fair  
    Cost     Losses     Value  
U.S. government obligations   $ 1,021     $ (7 )   $ 1,014  
Corporate obligations     629       (4 )     625  
    $ 1,650     $ (11 )   $ 1,639  
Schedule of Components of Inventory

The components of inventory are as follows (in thousands):

 

    March 31,     December 31,  
    2021     2020  
Lab material   $ 14,414     $ 1,028  
Raw materials     1,305       1,404  
Work in process     185       437  
Finished goods     122       170  
    $ 16,026     $ 3,039  
Schedule of Fair Value of Financial Instruments

The components of marketable debt securities are as follows (in thousands):

 

    As of March 31, 2021  
    Level 1     Level 2     Level 3     Total  
Marketable debt securities                                
U.S. government obligations   $ -     $ 1,009     $ -     $ 1,009  
Corporate obligations     -       2,522       -       2,522  
    $ -     $ 3,531     $ -     $ 3,531  

 

    As of December 31, 2020  
    Level 1     Level 2     Level 3     Total  
Marketable debt securities                                
U.S. government obligations   $ -     $ 1,014     $ -     $ 1,014  
Corporate obligations     -       625       -       625  
    $ -     $ 1,639     $ -     $ 1,639  
Schedule of Deferred Revenue

The following table disaggregates our deferred revenue by recognition period (in thousands):

 

    Deferred Revenue  
Recognition Period        
0-12 Months   $ 129  
13-24 Months     123  
Over 24 Months     26  
Total   $ 278  
Schedule of Disaggregation by Revenue

The following table disaggregates our revenue by revenue source for three months ended March 31, 2021 and 2020 (in thousands):

 

    For the Three Months Ended  
Revenue by Customer Type   March 31, 2021     March 31, 2020  
Contract manufacturing   $ 1,908     $ 1,723  
Retail and others     625       165  
Diagnostic services     12,738       -  
Total revenue   $ 15,271     $ 1,888